TP53 and cancer: SCARNA15 can lead to the modification of Ψ-39 on the U2 of the spliceosome, allowing for alternative splicing events that are associated with cancer through the modification of some central pathways relating to tumor suppressors (such as ATRX and p53) as an adaptive response to stress (105).